Citadel Advisors »

Xortx Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Xortx Therapeutics (XRTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Xortx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xortx Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xortx Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $70k 86k 0.81
2025-06-30 $36k 39k 0.93
2024-06-30 $23k 12k 1.89

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Xortx Therapeutics

Citadel Advisors
XTX Topco
UBS Group
Royal Bank of Canada
Hartland & Co
SBI Securities

View all funds holding Xortx Therapeutics